Arcturus Therapeutics Holdin

Stocks Under $10 Biotech Stocks Healthcare Stocks

$6.76

-0.32 (-4.52%)

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 14 78%

Hold 4 22%

Sell 0 0%

Price Target

Analyst Price Target +290.7% upside

Low Target $16.23

Average Target $26.41

High Target $33.18

Current Price $6.76

Current
$6.76

Target
$26.41

$16.23 $26.41 avg $33.18

Scenario Analysis

Bear Case

$16.23

140.1%

Low target

Base Case

$26.41

+290.7%

Avg target

Bull Case

$33.18

+390.8%

High target

Risk/Reward

2.8x

Favorable

Price in Context

52-Week High

$24.17

-72.0% from high

52-Week Low

$5.85

+15.6% from low

Target vs 52W High

$26.41

+9.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+23.4%
AMGN Amgen Inc	Hold	42	50%	$190.87	-44.9%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+160.4%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.1%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-67.8%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-13.0%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-31.3%